Rare diseases
Investigational molecules
Locations
Back to Italy2 668 clinical trials in Ranica, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Avutometinib and Defactinib for Patients with Recurrent Low-Grade Serous Ovarian Cancer
ItalyStudy of Drug Combination Treatment (Capecitabine, Oxaliplatin, Fluorouracil, Irinotecan) Guided by Liquid Biopsy Testing in Patients with Stage III and High-Risk Stage II Colon Cancer
ItalyStudy on the Safety and Effects of Temferon for Patients with Metastatic Renal Cell Carcinoma Using a Drug Combination
ItalyStudy on Fianlimab and Cemiplimab for Adults with Resectable Stage III and IV Melanoma
ItalyStudy on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
ItalyStudy Comparing Bomedemstat and Hydroxycarbamide for Patients with Essential Thrombocythemia
ItalyStudy on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
ItalyStudy on DMD06-MAB Injection for Duchenne Muscular Dystrophy in Non-Ambulant Patients
ItalyStudy on the Safety and Effectiveness of Etrumadenant, Quemliclustat, and Zimberelimab in Patients with Metastatic Colorectal Cancer
ItalyStudy on Gene Therapy with Atidarsagene Autotemcel for Patients with Metachromatic Leukodystrophy
ItalyStudy of Eribulin for Adults with Advanced Solitary Fibrous Tumor in Second or Third Line Treatment
ItalyStudy of NMD670 tablets to improve muscle strength in adults with TYPE 3 spinal muscular atrophy who can walk
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on membranoproliferative glomerulonephritis and related conditions, evaluating novel therapeutic approaches including iptacopan and pegcetacoplan for treating various forms of kidney inflammation.
Multiple trials aim to reduce proteinuria and improve long-term kidney function outcomes.
Comprehensive studies examining treatments for IgA Nephropathy and membranous nephropathy, including investigations of sparsentan and specialized antibody therapies for patients resistant to conventional treatments.
Focus on proteinuria reduction and preservation of renal function in various nephropathy types.
Advanced research into non-diabetic chronic kidney disease, exploring new therapeutic options including finerenone and investigating treatments for complications like hyperkalemia.
Studies aim to delay disease progression and improve standard of care outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
